Case Studies

Development and refinement of payer value messages for a novel urology treatment

26/04/2023

Author:

Sarah Bailey

About the Author

Article Tags

Early Payer Dialogue HTA HTA Process Launch Pricing

Share this article

Related articles

Articles

30.06.2025

Avoiding pitfalls: Top 5 reasons NICE HST/STA subm...

Most pharmaceutical products hoping to launch in the UK will be assessed by NICE as a Single Technol...

Articles

25.06.2025

Mastering NICE submissions: The three pillars for ...

Securing a positive recommendation from the National Institute for Health and Care Excellence (NICE)...